Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-045805

Director acquired 251 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
COHEN ALAIN J Director 2021-07-02 Grant or award +251 $39.72 $9,970 517 D
Loading xslF345X03/doc4.xml…